PremiumAnalyst Comment ERS 2026: Brensocatib cuts NCFB exacerbations in NTM history patients Brensocatib was FDA approved in August 2025, marking the first approved therapy for NCFB. GlobalData Healthcare
PremiumAnalyst Comment ERS 2026: Sanofi’s lunsekimig hits Phase IIb goals in asthma, Phase III set to follow
PremiumAnalyst Comment ESC 2026: oral semaglutide shows lower 3-year CV risk than injectable in T2D GlobalData Healthcare
PremiumAnalyst Comment ESC 2026: Head-to-head study compares inclisiran and bempedoic acid GlobalData Healthcare
PremiumAnalyst Comment ESC 2026: enlicitide extends oral PCSK9 benefits beyond LDL-C lowering GlobalData Healthcare
PremiumAnalyst Comment ESC 2026: laroprovstat evaluated to close the LDL-C treatment gap Katie Smith-Wong
PremiumAnalyst Comment Surveillance and vaccine could protect against higher cancer risk from Lynch syndrome GlobalData Healthcare
PremiumAnalyst Comment US Executive Order 14420 and potential implications for diphtheria vaccination GlobalData Healthcare
PremiumAnalyst Comment AstraZeneca trips in PD-1 bispecific market after Phase III NSCLC failure GlobalData Healthcare
PremiumAnalyst Comment Study finds metabolic biomarker signature to assist with early HNSCC detection GlobalData Healthcare
PremiumAnalyst Comment The changing landscape of childhood infectious disease in the US GlobalData Healthcare
PremiumAnalyst Comment Long-acting HIV therapies gain momentum, but pricing and access challenges remain GlobalData Healthcare
PremiumAnalyst Comment UK study finds sharp increase in type 2 diabetes incidence GlobalData Healthcare
PremiumAnalyst Comment FDA approval of mFLUSIVA highlights Moderna’s position in mRNA market GlobalData Healthcare
Analyst Comment Beyond memory: could changes in movement and the senses detect dementia earlier? GlobalData Healthcare
Analyst Comment D&D Pharmatechs’ zabopegdutide shows rapid, weight-loss-independent MASH benefit GlobalData Healthcare
Analyst Comment China’s rapid rise in drug development casts a long shadow over US oncology GlobalData Healthcare
Analyst Comment Minimum age threshold introduced for puberty blocker clinical trial GlobalData Healthcare
Analyst Comment European scientists advocate for integrative approach to obesity prevention GlobalData Healthcare
Analyst Comment Loneliness interventions do not have strong sustained effects on memory function GlobalData Healthcare
Analyst Comment Arrowhead gains EU authorisation for Redemplo in evolving FCS market GlobalData Healthcare
Analyst Comment Addressing sexual minority gaps in cervical and breast cancer screening GlobalData Healthcare
Analyst Comment EAN 2026: Real-world data supports safety and efficacy of AbbVie’s Vyalev in Parkinson’s GlobalData Healthcare
Analyst Comment EAN 2026: NeuroDerm spotlights Onerji fall reduction in advanced Parkinson’s disease GlobalData Healthcare
Analyst Comment EAN 2026: Meta-analysis finds no added benefit of Radicava/Rilutek combo in ALS GlobalData Healthcare
Analyst Comment EAN 2026: Regeneron highlights disease control potential of cemdisiran in gMG GlobalData Healthcare